Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Piroxicam

🥰Excellent
Catalog No. T0758Cas No. 36322-90-4
Alias CP-16171

Piroxicam (CP-16171) is a non-specific COX inhibitor.

Piroxicam

Piroxicam

🥰Excellent
Purity: 99.59%
Catalog No. T0758Alias CP-16171Cas No. 36322-90-4
Piroxicam (CP-16171) is a non-specific COX inhibitor.
Pack SizePriceAvailabilityQuantity
500 mg$45In Stock
1 g$53In Stock
1 mL x 10 mM (in DMSO)$50In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Piroxicam"

Select Batch
Purity:99.59%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Piroxicam (CP-16171) is a non-specific COX inhibitor.
Targets&IC50
COX-1:47 μM, COX-2 (human monocyte):25 μM
In vitro
Piroxicam induces activation of extracellular signal-regulated kinase (ERK) in neurones and phosphorylation of heavy molecular weight neurofilaments, cytoskeletal substrates of ERK in rat spinal cord cultures. Piroxicam and NS-398 protect neurones against hypoxia/reperfusion in rat spinal cord cultures. [1]
In vivo
Piroxicam at doses higher than 0.04%, strongly inhibits the development of GST-P-positive and neoplastic nodules as well as fibrosis, cirrhosis and formation of 8-hydroxydeoxyguanosine (8-OHdG) adducts in rats. [2] Piroxicam increases the expression of all three MHC antigens compared to either control or azoxymethane (AOM)-treated rats. Piroxicam up-regulates colonic MHC antigen expression in the AOM model of colonic carcinogenesis. [3] Piroxicam combined with Cisplatin has antitumor activity against oral malignant melanoma (OMM) and oral squamous cell carcinoma (SCC) in rats. [4] Piroxicam inhibits prostaglandin synthesis through cyclooxygenase blockade in dog, and Piroxicam does not have any direct cytotoxic effects in vitro. [5] Piroxicam also binds strongly to plasma proteins and Piroxicam could stop Ochratoxin A (OTA) -binding and transport into target organs, thereby preventing its nephrotoxicity in rats. Piroxicam prevents the enzymuria induced by OTA and increases renal elimination of OTA in rats. [6]
AliasCP-16171
Chemical Properties
Molecular Weight331.35
FormulaC15H13N3O4S
Cas No.36322-90-4
SmilesOC=1C=2C(S(=O)(=O)N(C)C1C(NC3=CC=CC=N3)=O)=CC=CC2
Relative Density.1.563 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
Ethanol: 1 mg/mL (3.01 mM)
DMSO: 45 mg/mL (135.81 mM)
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM3.0180 mL15.0898 mL30.1796 mL150.8978 mL
DMSO
1mg5mg10mg50mg
5 mM0.6036 mL3.0180 mL6.0359 mL30.1796 mL
10 mM0.3018 mL1.5090 mL3.0180 mL15.0898 mL
20 mM0.1509 mL0.7545 mL1.5090 mL7.5449 mL
50 mM0.0604 mL0.3018 mL0.6036 mL3.0180 mL
100 mM0.0302 mL0.1509 mL0.3018 mL1.5090 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Piroxicam | purchase Piroxicam | Piroxicam cost | order Piroxicam | Piroxicam chemical structure | Piroxicam in vivo | Piroxicam in vitro | Piroxicam formula | Piroxicam molecular weight